Westfield Capital Management
ASND icon

Westfield Capital Management’s Ascendis Pharma ASND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$941M Sell
5,451,401
-27,858
-0.5% -$4.81M 3.95% 2
2025
Q1
$854M Sell
5,479,259
-48,980
-0.9% -$7.63M 4.16% 1
2024
Q4
$761M Buy
5,528,239
+394,473
+8% +$54.3M 3.31% 4
2024
Q3
$767M Buy
5,133,766
+170,942
+3% +$25.5M 3.46% 4
2024
Q2
$677M Buy
4,962,824
+887,610
+22% +$121M 3.33% 4
2024
Q1
$616M Buy
4,075,214
+44,580
+1% +$6.74M 3.23% 2
2023
Q4
$508M Buy
4,030,634
+228,457
+6% +$28.8M 2.96% 2
2023
Q3
$356M Buy
3,802,177
+170,465
+5% +$16M 2.43% 4
2023
Q2
$324M Buy
3,631,712
+485,586
+15% +$43.3M 2.06% 6
2023
Q1
$337M Sell
3,146,126
-12,042
-0.4% -$1.29M 2.38% 3
2022
Q4
$386M Buy
3,158,168
+247,444
+9% +$30.2M 2.98% 2
2022
Q3
$301M Buy
2,910,724
+122,415
+4% +$12.6M 2.39% 4
2022
Q2
$259M Buy
2,788,309
+153,282
+6% +$14.2M 2.04% 5
2022
Q1
$309M Sell
2,635,027
-5,907
-0.2% -$693K 1.98% 6
2021
Q4
$355M Buy
2,640,934
+529,441
+25% +$71.2M 2.11% 6
2021
Q3
$337M Buy
2,111,493
+95,566
+5% +$15.2M 2.03% 6
2021
Q2
$265M Buy
2,015,927
+148,234
+8% +$19.5M 1.59% 8
2021
Q1
$241M Buy
1,867,693
+137,812
+8% +$17.8M 1.5% 8
2020
Q4
$289M Sell
1,729,881
-59,893
-3% -$9.99M 1.71% 7
2020
Q3
$276M Buy
1,789,774
+351,109
+24% +$54.2M 1.79% 6
2020
Q2
$213M Buy
1,438,665
+75,323
+6% +$11.1M 1.46% 10
2020
Q1
$154M Buy
1,363,342
+102,586
+8% +$11.6M 1.35% 12
2019
Q4
$175M Buy
1,260,756
+136,702
+12% +$19M 1.25% 15
2019
Q3
$108M Buy
1,124,054
+152,302
+16% +$14.7M 0.87% 27
2019
Q2
$112M Buy
971,752
+285,207
+42% +$32.8M 0.84% 33
2019
Q1
$80.8M Buy
686,545
+147,425
+27% +$17.4M 0.61% 58
2018
Q4
$33.8M Sell
539,120
-42,614
-7% -$2.67M 0.29% 109
2018
Q3
$41.2M Buy
581,734
+157,159
+37% +$11.1M 0.29% 117
2018
Q2
$28.2M Buy
+424,575
New +$28.2M 0.21% 154